000952 Hubei Guangji Pharmaceutical
- 6.02
- -0.47-7.24%
Hubei Guangji Pharmaceutical News
Guangji Pharmaceutical: Announcement on Abnormal Fluctuations in Stock Trading
Guangji Pharmaceutical: Announcement on Obtaining a Drug Registration Certificate for Fibustel Tablets
Guangji Pharmaceutical: “Asset Assessment Report” Beijing Asian Super League Review (2024) No. A185 - Text
Guangji Pharmaceutical: Announcement on the public listing of the wholly-owned subsidiary Hubei Guanghua Pharmaceutical Co., Ltd. to increase capital and expand shares
Guangji Pharmaceutical: Announcement of Resolutions of the 3rd (Interim) Meeting of the 11th Board of Supervisors
Guangji Pharmaceutical: Announcement of Resolutions of the Fourth (Interim) Meeting of the 11th Board of Directors
Guangji Pharmaceutical: Progress Notice on Participation in Bankruptcy and Reorganization Investments
Guangji Pharmaceutical: “Hubei Guanghua Pharmaceutical Co., Ltd. Audit Report” (2023) Daxin Review [2024] No. 2-00441
Guangji Pharmaceutical: Announcement on changing the signed certified public accountant
Guangji Pharmaceutical: “Audit Report of Hubei Guanghua Pharmaceutical Co., Ltd.” (January-June 2024), Lianda Review [2024] No. 0150
Guangji Pharmaceutical: Notice on Obtaining a Notice of Approval for Supplementary Applications for Valaciclovir Hydrochloride Tablets
Guangji Pharmaceutical: Announcement on signing a strategic cooperation agreement with Qingdao Guoxin Pharmaceutical Co., Ltd.
Guangji Pharmaceutical: Announcement on signing a strategic cooperation agreement with Pingguang Pharmaceutical Co., Ltd.
Guangji Pharmaceutical: Announcement of Resolutions of the Third (Interim) Meeting of the 11th Board of Directors
Guangji Pharmaceutical: Prompt Announcement on Pre-listing of Wholly-owned Subsidiaries on Capital Increase and Stock Expansion
Guangji Pharmaceutical: Announcement on the Appointment of Senior Executives and Securities Affairs Representatives
Guangji Pharmaceutical: Announcement of Supervisory Committee Resolutions
Guangji Pharmaceutical: Report for the third quarter of 2024
Guangji Pharmaceutical: “Hubei Guangji Pharmaceutical Technology Co., Ltd. Net Asset Special Audit Report” Lianda Special Article [2024] No. 0235
Guangji Pharmaceutical: “Hubei Guangji Pharmaceutical Technology Co., Ltd. Audit Report” Daxin Review [2023] No. 2-00644
No Data